Investigation of the human metabolism and disposition of the prolyl hydrolase inhibitor daprodustat using IV microtracer with Entero‐Test bile string

Investigation of the human metabolism and disposition of the prolyl hydrolase inhibitor daprodustat using IV microtracer with Entero‐Test bile string

Abstract Daprodustat is an oral small molecule hypoxia‐inducible factor (HIF) prolyl hydroxylase inhibitor (PHI) approved in Japan and the United States for the treatment of anemia associated with chronic kidney disease. This phase 1, nonrandomized, 2‐period, crossover study in 6 healthy men charact...

Descrizione completa

Dettagli Bibliografici
Autori principali: Guoying Tai, Fangming Xia, Cathy Chen, Adrian Pereira, Jill Pirhalla, Xiusheng Miao, Graeme Young, Claire Beaumont, Liangfu Chen
Natura: Articolo
Lingua:English
Pubblicazione: Wiley 2023-12-01
Serie:Pharmacology Research & Perspectives
Soggetti:
daprodustat
excretion
metabolism
metabolite structural identification
oral absorption
quantitative characterizations
Accesso online:https://doi.org/10.1002/prp2.1145

Accesso online

https://doi.org/10.1002/prp2.1145

Documenti analoghi